UB Paderborn / Katalog / Suche / in CDI

Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug

British journal of clinical pharmacology, 2018-05, Vol.84 (5), p.997-1005

2018

Volltextzugriff (PDF)

Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database

British journal of clinical pharmacology, 2016-10, Vol.82 (4), p.1058-1068

2016

Volltextzugriff (PDF)

mRNA expression of drug metabolism enzymes and transporter genes at birth using human umbilical cord blood

Fundamental & clinical pharmacology, 2018-08, Vol.32 (4), p.422-435

2018

Volltextzugriff (PDF)

Extremely low dose of 6‐mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations

Journal of clinical pharmacy and therapeutics, 2021-02, Vol.46 (1), p.74-77

2021

Volltextzugriff (PDF)

Population Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid Following Administration of Mycophenolate Mofetil in De Novo Pediatric Renal-Transplant Patients

Journal of clinical pharmacology, 2010-11, Vol.50 (11), p.1280-1291

2010

Volltextzugriff (PDF)

A Consensus-Based Checklist for Reporting of Survey Studies (CROSS)

Journal of general internal medicine : JGIM, 2021-10, Vol.36 (10), p.3179-3187

2021

Volltextzugriff (PDF)

Determination of ciprofloxacin in plasma by micro-liquid chromatography-mass spectrometry: An adapted method for neonates

Biomedical chromatography, 2011-07, Vol.25 (7), p.827-832

2011

Volltextzugriff (PDF)

Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review

Pharmaceutics, 2021-05, Vol.13 (5), p.695

2021

Volltextzugriff (PDF)

Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease

British journal of clinical pharmacology, 2015-11, Vol.80 (5), p.1197-1207

2015

Volltextzugriff (PDF)

Clinical trials in neonates: How to optimise informed consent and decision making? A European Delphi survey of parent representatives and clinicians

PloS one, 2018-06, Vol.13 (6), p.e0198097-e0198097

2018

Volltextzugriff (PDF)

Key factors associated with 6‐thioguanine and 6‐methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease

British journal of clinical pharmacology, 2024-01, Vol.90 (1), p.209-219

2024

Volltextzugriff (PDF)

Cystatin C as a potential biomarker for dosing of renally excreted drugs

British journal of clinical pharmacology, 2015-07, Vol.80 (1), p.20-27

2015

Volltextzugriff (PDF)

Integration of Pharmacogenetics and Pharmacogenomics in Drug Development: Implications for Regulatory and Medical Decision Making in Pediatric Diseases

Journal of clinical pharmacology, 2012-05, Vol.52 (5), p.704-716

2012

Volltextzugriff (PDF)

Population pharmacokinetics of tacrolimus in children with nephrotic syndrome

British journal of clinical pharmacology, 2018-08, Vol.84 (8), p.1748-1756

2018

Volltextzugriff (PDF)

Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy

British journal of clinical pharmacology, 2011-04, Vol.71 (4), p.575-584

2011

Volltextzugriff (PDF)

A physiological approach to renal clearance: From premature neonates to adults

British journal of clinical pharmacology, 2024-04, Vol.90 (4), p.1066-1080

2024

Volltextzugriff (PDF)

Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus

European journal of clinical pharmacology, 2022-06, Vol.78 (6), p.1003-1010

2022

Volltextzugriff (PDF)

Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants

Journal of antimicrobial chemotherapy, 2019-08, Vol.74 (8), p.2128-2138

2019

Volltextzugriff (PDF)

Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome

Journal of the American Society of Nephrology, 2018-07, Vol.29 (7), p.2000-2013

2018

Volltextzugriff (PDF)

Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1155-1164

2021

Volltextzugriff (PDF)

How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper

British journal of clinical pharmacology, 2022-12, Vol.88 (12), p.5017-5033

2022

Volltextzugriff (PDF)

Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review

Frontiers in pharmacology, 2021-04, Vol.12, p.635345

2021

Volltextzugriff (PDF)

Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis

International journal of molecular sciences, 2022-10, Vol.23 (19), p.11885

2022

Volltextzugriff (PDF)

External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings

British journal of clinical pharmacology, 2013-04, Vol.75 (4), p.1068-1080

2013

Volltextzugriff (PDF)

Melatonin Levels in Preterm and Term Infants and Their Mothers

International journal of molecular sciences, 2019-05, Vol.20 (9), p.2077

2019

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Developmental pharmacogenetics of CYP2C19 in neonates and young infants: omeprazole as a probe drug

Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database

mRNA expression of drug metabolism enzymes and transporter genes at birth using human umbilical cord blood

Extremely low dose of 6‐mercaptopurine in a Chinese child with acute lymphoblastic leukaemia and multiple pharmacogenetic mutations

Population Pharmacokinetics and Pharmacogenetics of Mycophenolic Acid Following Administration of Mycophenolate Mofetil in De Novo Pediatric Renal-Transplant Patients

A Consensus-Based Checklist for Reporting of Survey Studies (CROSS)

Determination of ciprofloxacin in plasma by micro-liquid chromatography-mass spectrometry: An adapted method for neonates

Drug Safety in Translational Paediatric Research: Practical Points to Consider for Paediatric Safety Profiling and Protocol Development: A Scoping Review

Population pharmacokinetics and dosing optimization of teicoplanin in children with malignant haematological disease

Clinical trials in neonates: How to optimise informed consent and decision making? A European Delphi survey of parent representatives and clinicians

Key factors associated with 6‐thioguanine and 6‐methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease

Cystatin C as a potential biomarker for dosing of renally excreted drugs

Integration of Pharmacogenetics and Pharmacogenomics in Drug Development: Implications for Regulatory and Medical Decision Making in Pediatric Diseases

Population pharmacokinetics of tacrolimus in children with nephrotic syndrome

Determinants of mercaptopurine toxicity in paediatric acute lymphoblastic leukemia maintenance therapy

A physiological approach to renal clearance: From premature neonates to adults

Pharmacokinetics of mycophenolic acid and external evaluation of two limited sampling strategies of drug exposure in patients with juvenile systematic lupus erythematosus

Population pharmacokinetic meta-analysis of individual data to design the first randomized efficacy trial of vancomycin in neonates and young infants

Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome

Developmental population pharmacokinetics of caffeine in Chinese premature infants with apnoea of prematurity: A post‐marketing study to support paediatric labelling in China

How paediatric drug development and use could benefit from OMICs: A c4c expert group white paper

Contribution of Population Pharmacokinetics of Glycopeptides and Antifungals to Dosage Adaptation in Paediatric Onco-hematological Malignancies: A Review

Improved HPLC Quantification of 6-Mercaptopurine Metabolites in Red Blood Cells: Monitoring Data and Literature Analysis

External evaluation of population pharmacokinetic models of vancomycin in neonates: the transferability of published models to different clinical settings

Melatonin Levels in Preterm and Term Infants and Their Mothers

Suchergebnisse filtern